Heart Health Protection When people who are overweight use GLP-1 medications, they tend to experience broad cardiovascular and metabolic health improvements, depending on the medication
In the primary Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023), retatrutide was studied across several dose levels, including: 1 mg (low dose) 4 mg (mid dose) 8 mg (higher dose) 12 mg (highest dose) These doses were administered as once-weekly subcutaneous injections
1.1 per 1,000 person-years
As a result of this rapid degradation, only about 10-15% of released GLP-1 reaches the pancreas intact
GLP-1 agonists, such as Wegovy, have been shown to suppress appetite, which may lead to decreased food intake
COST : $299 FOR THE FIRST MONTH Then cost varies by type of GLP and dose needed Discounts for doing a 3 month program We value a personalized treatment